While PCSK9 became one of the most promising targets for the improvement of hypercholesterolemia, as for its inhibitors constituted a new class of lipid-lowering drugs [10, 11], whether PCSK9 participates in regulating T synthesis remains unknown. Here, PCSK9 is linked to familial hypercholesterolemia.